We offer technology licensing to various companies for a "perfect alcohol-based sanitizer" effective against food poisoning bacteria that are resistant to standard alcohol sanitizers. The reason these bacteria survive even at 100℃ is their ability to synthesize a robust structure called a spore. We have discovered that substance Y inhibits spore formation, and by incorporating it into alcohol-based sanitizers sterilization becomes possible. Furthermore, substance Y is safe and secure; when added to food products, the bacteria can be killed by heating at 100℃. We are therefore also proposing a new sterilization method.
A startup developing kidney disease treatments and cell therapies using iPS cell technology, expanding its achievements in the kidney disease field while advancing applications to the liver and pancreas.
Development of cancer treatment equipment using optical electromagnetic waves
A startup advancing drug discovery through proprietary platform technology that selectively delivers drugs to immune cells, both through in-house development and collaborative partnerships. It aims to create novel therapies for intractable diseases by controlling immune responses.
By utilizing DNA as a functional organic material, we are developing a “DNA linker technology” that enables precise conjugation of antibodies with drugs and functional molecules, alongside related applications such as cell adhesion and enzyme-free nucleic acid detection. Our unique molecular design enhances the performance and multifunctionality of diverse materials, establishing foundational technologies for ADC drug development, 3D cell models, and diagnostic platforms. Furthermore, we expand these technologies into research support and collaborative R&D to accelerate industrial application and societal implementation.
